Huron Capital has sold its interest in Labstat International ULC to Alaris Royalty Corp. and Labstat's management, reflecting a strategic move in the growing tobacco testing market.
Target Company Overview
Labstat International ULC, commonly referred to as Labstat, is a prominent provider of chemistry and toxicology testing services, primarily serving global tobacco manufacturers. Based in Kitchener, Ontario, the company specializes in both regulatory compliance and commercial testing. Labstat has established itself as the leading independent laboratory for measuring chemical emissions from tobacco smoke and smokeless tobacco products. It also assesses the biological impact of these products, which is crucial for regulatory agencies and market participants who must meet mandatory reporting requirements.
Founded to address the burgeoning needs of the tobacco industry, Labstat plays a vital role in facilitating compliance with various government regulations related to tobacco control. The company's capabilities enable it to support governmental agencies as well as industry stakeholders, ensuring safe and compliant products in the market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The testing and analytical services industry in Canada has gained significant traction, especially in the wake of evolving regulations surrounding tobacco products. The Canadian government has taken substantial measures to control tobacco consumption t
Similar Deals
Alaris Royalty Corp.
invested in
Labstat International ULC
in 2012
in a Buyout deal